Sean Lee
Stock Analyst at HC Wainwright & Co.
(4.23)
# 446
Out of 5,055 analysts
97
Total ratings
37.23%
Success rate
28.17%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CTSO Cytosorbents | Maintains: Neutral | $1 → $0.75 | $0.66 | +13.64% | 14 | Nov 14, 2025 | |
| SENS Senseonics Holdings | Maintains: Buy | $1.4 → $19 | $6.26 | +195.53% | 3 | Nov 6, 2025 | |
| PSTV Plus Therapeutics | Maintains: Buy | $3 → $2 | $0.51 | +291.01% | 13 | Nov 3, 2025 | |
| ATEC Alphatec Holdings | Maintains: Buy | $20 → $24 | $19.74 | +21.58% | 13 | Oct 31, 2025 | |
| NVAX Novavax | Maintains: Buy | $10 → $11 | $6.97 | +57.82% | 2 | Oct 23, 2025 | |
| DWTX Dogwood Therapeutics | Maintains: Buy | $10 → $12 | $5.57 | +115.44% | 2 | Sep 30, 2025 | |
| AKTX Akari Therapeutics, | Reiterates: Buy | $1.6 | $0.53 | +202.57% | 2 | Sep 9, 2025 | |
| CASI CASI Pharmaceuticals | Reiterates: Buy | $4 | $1.26 | +217.46% | 10 | Sep 3, 2025 | |
| MYO Myomo | Maintains: Buy | $9.5 → $5 | $0.82 | +512.82% | 6 | Aug 12, 2025 | |
| KZIA Kazia Therapeutics | Maintains: Buy | $2 → $13 | $6.27 | +107.34% | 5 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $7.56 | +85.31% | 14 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $78.04 | -48.74% | 10 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $8.77 | +25.43% | 3 | Mar 26, 2025 |
Cytosorbents
Nov 14, 2025
Maintains: Neutral
Price Target: $1 → $0.75
Current: $0.66
Upside: +13.64%
Senseonics Holdings
Nov 6, 2025
Maintains: Buy
Price Target: $1.4 → $19
Current: $6.26
Upside: +195.53%
Plus Therapeutics
Nov 3, 2025
Maintains: Buy
Price Target: $3 → $2
Current: $0.51
Upside: +291.01%
Alphatec Holdings
Oct 31, 2025
Maintains: Buy
Price Target: $20 → $24
Current: $19.74
Upside: +21.58%
Novavax
Oct 23, 2025
Maintains: Buy
Price Target: $10 → $11
Current: $6.97
Upside: +57.82%
Dogwood Therapeutics
Sep 30, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $5.57
Upside: +115.44%
Akari Therapeutics,
Sep 9, 2025
Reiterates: Buy
Price Target: $1.6
Current: $0.53
Upside: +202.57%
CASI Pharmaceuticals
Sep 3, 2025
Reiterates: Buy
Price Target: $4
Current: $1.26
Upside: +217.46%
Myomo
Aug 12, 2025
Maintains: Buy
Price Target: $9.5 → $5
Current: $0.82
Upside: +512.82%
Kazia Therapeutics
Jul 10, 2025
Maintains: Buy
Price Target: $2 → $13
Current: $6.27
Upside: +107.34%
May 9, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $7.56
Upside: +85.31%
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $78.04
Upside: -48.74%
Mar 26, 2025
Reiterates: Buy
Price Target: $11
Current: $8.77
Upside: +25.43%